Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

NextCell Pharma AB: NextCell Presents Quarterly Report

NextCell Pharma

NextCell Pharma AB ("NextCell" or the "Company") invites investors, analysts and media to an investor presentation in conjunction with the publication of the Company's second interim report for the 2024/2025 financial year, on Thursday, 25 April 2025.

CEO Mathias Svahn will present the Company, the report, and the results from the subgroup analysis published on 7 April 2025. The Company's subsidiaries, Cellaviva and QVance, will also be presented by their respective CEOs: Sofie Falk Jansson (Cellaviva) and Lindsay Davies (QVance). Attendees, both on-site and online, will have the opportunity to ask questions. The presentation will be available for on-demand streaming.

Time: Friday, 25 April 2025, at 2:00 PM

Venue: Redeye, Mäster Samuelsgatan 42, Stockholm, Sweden

Registration (for on-site attendance): Please register by email to events@redeye.se

Webcast (no pre-registration required): Please follow this link:

https://www.redeye.se/events/1095576/business-update-nextcell-pharma

 

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.